Exponent (EXPO) had its price target lowered by JPMorgan Chase & Co. from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Exponent (NASDAQ:EXPO) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Exponent, Inc. (NASDAQ:EXPO) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Exponent Inc (EXPO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst AI ... [Yahoo! Finance]
Exponent, Inc. (EXPO) Q4 2025 Earnings Call Transcript [Seeking Alpha]